MarketCapTrends
LFCR
Lifecore Biomedical, Inc. (LFCR)
NASDAQ · Healthcare

Lifecore Biomedical, Inc. Long Term Debt 2010–2025

Lifecore Biomedical, Inc. annual/quarterly long term debt history from 2011 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.

  • Lifecore Biomedical, Inc. long term debt for the quarter ending May 25, 2025 were 130.4M, a 4.63% increase year-over-year.
  • Lifecore Biomedical, Inc. long term debt for 2025 were 130.4M, a 4.63% increase from 2024.
  • Lifecore Biomedical, Inc. long term debt for 2024 were 124.7M, a 46.95% increase from 2023.
  • Lifecore Biomedical, Inc. long term debt for 2023 were 84.8M, a 13.59% decrease from 2022.
  • Lifecore Biomedical, Inc. long term debt for 2022 were 98.2M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Lifecore Biomedical, Inc. Annual Long Term Debt (Millions of US $)
2025$130
2024$125
2023$85
2022$98
2021$165
2020$113
2019$97
2018$42
2017$47
2016$54
2015$43
2014$34
2013$40
2012$47
2011$16
Lifecore Biomedical, Inc. Quarterly Long Term Debt (Millions of US $)
2025-05-25$130
2024-05-26$125
2023-05-28$85
2022-05-29$98
2021-05-30$165
2020-05-31$113
2019-05-26$97
2018-05-27$42
2017-05-28$47
2016-05-29$54
2015-05-31$43
2014-05-25$34
2013-05-26$40
2012-05-27$47
2011-05-29$16

Lifecore Biomedical, Inc. Long Term Debt — FAQ

Lifecore Biomedical, Inc. (LFCR) long term debt over the last 16 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see LFCR's long term debt history?

The chart and table above show Lifecore Biomedical, Inc.'s long term debt by year and by quarter, including the growth rate.